|
|
Details: |
|
|
Researches and develops growth factor blockers and anti-cancer vaccines. Includes clinical programs, investor details and overview of company in New York City. (Nasdaq: IMCL)
|
URL: |
http://www.imclone.com/
|
Title: |
ImClone.com |
Image: |
|
Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Imclone Systems Inc.. Researches and develops growth factor blockers and anti-cancer vaccines. |
Similar: |
|
|
|
Related Sites |
|
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
Morphochem (Popularity: ): Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Modular Genetics, Inc. (Popularity: ): Supporting basic research, drug design, drug screening and chemical synthesis.
Myogen, Inc. (Popularity: ): Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product ...
Virax Holdings, Ltd. (Popularity: ): Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. ...
Maxygen, Inc. (Popularity: ): Develops proprietary proteins modifications including PEG, glycosylation and vaccines. Overview of technologies, clinical trial pipeline, investor data and careers in ...
Cyano Biotech GmbH (Popularity: ): Identifies and characterises natural products from cyanobacteria and optimises their pharmacological activities employing a biocombinatorial approach. Berlin, Germany.
|
|
Popular Sites |
|
African Reptiles and Venom (Popularity: ): Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
Bavarian Nordic (Popularity: ): Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV ...
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
BioMarin Pharmaceutical Inc. (Popularity: ): Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters ...
|
|
Related Press |
|
The SI Names Brett Dody to Lead Intelligence Systems Group (Popularity: ): CHANTILLY, Va., Aug. 17, 2011 -- The SI Organization, Inc. (the SI) has named Brett Dody as the vice president ...
General Dynamics Wins Cisco Federal Systems Integrator of the Year Award at Cisco Partner Summit (Popularity: ): General Dynamics C4 Systems and General Dynamics Information Technology announced today that the companies received a Cisco Partner Summit regional ...
Magna announces final results of substantial issuer bid (Popularity: ): Magna International Inc. (TSX: MG.A; NYSE: MGA) today announced the final results of its offer to purchase up to U.S.$1,536,600,000 ...
Investing Systems' New Research Lab Delivers Spectacular One-Day Gains for Stock Traders (Popularity: ): Investing Systems announced today the results of their daily stock scans in the Research Lab. The Investing Systems Research Lab ...
Burglar alarm systems Becomes Essential for Every home (Popularity: ): Santa Barbara, CA ( press.abc-directory ) January 19, 2010 -When it comes to burglar alarm systems, people always have confusions ...
|
|
Related Articles |
|
|
|
|